Research and Markets: PharmaPoint: Non-Small Cell Lung Cancer – Italy Drug … – Fort Mills Times

by lowes1 on September 20, 2013

Research and Markets: PharmaPoint: Non-Small Cell Lung Cancer – Italy Drug
Fort Mills Times
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy. However, the launch of targeted therapies for patients 

and more »

View full post on lung cancer – Google News

Leave a Comment

Previous post:

Next post: